options and restricted stock grants may be granted under the 2009 Stock Plan and (ii) the maximum number of shares that can be awarded to any individual in any one calendar year. On April 13, 2015, the Board of Directors adopted, and our stockholders approved on June 2, 2015, an amendment that replenished the authorized plan shares, increasing the number of shares of Class D common stock available for grant back up to 8,250,000 shares. Our new stock option and restricted stock plan (“2019 Equity and Performance Incentive Plan”), currently in effect was approved by the stockholders at the Company’s annual meeting on May 21, 2019. The Board of Directors adopted, and on May 21, 2019, our stockholders approved, the 2019 Equity and Performance Incentive Plan which is funded with 5,500,000 shares of Class D Common Stock. The Company uses an average life for all option awards. The Company settles stock options upon exercise by issuing stock. As of March 31, 2022, 5,884,252 shares of Class D common stock and 2,000,000 shares of Class A common stock were available for grant under the 2019 Equity and Performance Incentive Plan.
On June 12, 2019, the Compensation Committee (“Compensation Committee”) of the Board of Directors of the Company awarded Catherine Hughes, Chairperson, 427,148 restricted shares of the Company’s Class D common stock, and stock options to purchase 189,843 shares of the Company’s Class D common stock. The grants were effective June 5, 2020 and vested on January 6, 2021.
On June 12, 2019, the Compensation Committee awarded Alfred Liggins, Chief Executive Officer and President, 711,914 restricted shares of the Company’s Class D common stock, and stock options to purchase 316,406 shares of the Company’s Class D common stock. The grants were effective June 5, 2020 and vested on January 6, 2021.
On June 12, 2019, the Compensation Committee awarded Peter Thompson, Chief Financial Officer, 243,750 restricted shares of the Company’s Class D common stock, and stock options to purchase 108,333 shares of the Company’s Class D common stock. The grants were effective June 5, 2020 and vested on January 6, 2021.
On June 12, 2019, the Compensation Committee awarded David Kantor, Chief Executive Officer – Radio Division, 211,838 restricted shares of the Company’s Class D common stock, and stock options to purchase 94,150 shares of the Company’s Class D common stock. The grants were effective June 5, 2020 and vested on January 6, 2021.
Pursuant to the terms of each of our stock plans and subject to the Company’s insider trading policy, a portion of each recipient’s vested shares may be sold in the open market for tax purposes on or about the vesting dates.
Stock-based compensation expense for the three months ended March 31, 2022 and 2021, was $124,000 and $253,000, respectively.
The Company granted 6,887 stock options during the three months ended March 31, 2022 and granted 20,000 stock options during the three months ended March 31, 2021.
Transactions and other information relating to stock options for the three months ended March 31, 2022, are summarized below:
| | | | | | | | | | |
| | | | | | | Weighted-Average | | | |
| | | | | | | Remaining | | Aggregate |
| | Number of | | Weighted-Average | | Contractual Term | | Intrinsic |
| | Options | | Exercise Price | | (In Years) | | Value |
Outstanding at December 31, 2021 | | 3,771,000 | | $ | 2.18 | | 5.68 | | $ | 4,660,000 |
Grants | | 7,000 | | $ | 3.63 | | — | | | — |
Exercised | | — | | $ | — | | — | | | — |
Forfeited/cancelled/expired/settled | | — | | $ | — | | — | | | — |
Balance as of March 31, 2022 | | 3,778,000 | | $ | 2.18 | | 5.44 | | $ | 11,270,000 |
Vested and expected to vest at March 31, 2022 | | 3,777,000 | | $ | 2.18 | | 5.44 | | $ | 11,270,000 |
Unvested at March 31, 2022 | | 11,000 | | $ | 7.26 | | 9.51 | | $ | — |
Exercisable at March 31, 2022 | | 3,767,000 | | $ | 2.16 | | 5.43 | | $ | 11,270,000 |
The aggregate intrinsic value in the table above represents the difference between the Company’s stock closing price on the last day of trading during the three months ended March 31, 2022, and the exercise price, multiplied by the number of shares that would have been received by the holders of in-the-money options had all the option holders exercised their options on March 31, 2022. This amount changes based on the fair market value of the Company’s stock.